A detailed history of Man Group PLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Man Group PLC holds 619,927 shares of BBIO stock, worth $15.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
619,927
Holding current value
$15.3 Million
% of portfolio
0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$23.0 - $31.04 $14.3 Million - $19.2 Million
619,927 New
619,927 $15.7 Million
Q4 2023

Feb 14, 2024

BUY
$24.02 - $43.89 $170,542 - $311,619
7,100 New
7,100 $286,000
Q4 2022

Feb 14, 2023

SELL
$6.74 - $11.52 $97,163 - $166,072
-14,416 Reduced 33.46%
28,673 $218,000
Q3 2022

Nov 14, 2022

BUY
$7.94 - $12.36 $173,115 - $269,485
21,803 Added 102.43%
43,089 $429,000
Q2 2022

Aug 15, 2022

SELL
$5.21 - $12.14 $228,307 - $531,986
-43,821 Reduced 67.31%
21,286 $193,000
Q1 2022

May 16, 2022

BUY
$7.34 - $17.16 $477,885 - $1.12 Million
65,107 New
65,107 $661,000
Q3 2021

Nov 15, 2021

SELL
$46.87 - $64.24 $213,352 - $292,420
-4,552 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$46.47 - $63.93 $2.56 Million - $3.53 Million
-55,146 Reduced 92.37%
4,552 $278,000
Q1 2021

May 17, 2021

SELL
$55.47 - $72.35 $4.34 Million - $5.66 Million
-78,287 Reduced 56.74%
59,698 $3.68 Million
Q4 2020

Feb 16, 2021

BUY
$38.38 - $71.11 $535,899 - $992,908
13,963 Added 11.26%
137,985 $9.81 Million
Q3 2020

Nov 16, 2020

BUY
$27.2 - $42.19 $169,646 - $263,139
6,237 Added 5.3%
124,022 $4.65 Million
Q2 2020

Aug 14, 2020

BUY
$22.22 - $35.69 $2.62 Million - $4.2 Million
117,785 New
117,785 $3.84 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.65B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.